Shares Magazine
0.78p+0.03 (+3.33%)24 Dec 2024, 12:22
Jump to:
Physiomics PLC Fundamentals
| Company Name | Physiomics PLC | Last Updated | 2024-12-24 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 203.209 m | Market Cap | £1.57 m |
| PE Ratio | 0.00 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | £-0.00 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.4958 | Cash Equity Ratio | 0.6763 |
| Quick Ratio | 2.4415 | Current Ratio | 2.87 |
| Price To Book Value | 5.5741 | ROCE | 0 |
Physiomics PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Physiomics PLC Company Financials
| Assets | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tangible Assets | £16,829.00 | £7,757.00 | £14,365.00 | £15,700.00 |
| Intangible Assets | £4,379.00 | £5,479.00 | £3,005.00 | £3,435.00 |
| Investments | 0 | 0 | 0 | 0 |
| Total Fixed Assets | £21,208.00 | £13,416.00 | £17,765.00 | £19,135.00 |
| Stocks | 0 | 0 | 0 | 0 |
| Debtors | £150,922.00 | £147,781.00 | £271,155.00 | £132,227.00 |
| Cash & Equivalents | £191,072.00 | £416,592.00 | £687,674.00 | £1.04 m |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | £422,603.00 | £674,393.00 | £1.12 m | £1.32 m |
| Liabilities | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Creditors within 1 year | £140,076.00 | £142,673.00 | £140,609.00 | £157,570.00 |
| Creditors after 1 year | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £140,076.00 | £142,673.00 | £140,609.00 | £157,570.00 |
| Net assets | £282,527.00 | £531,720.00 | £974,807.00 | £1.17 m |
| Equity | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Called up share capital | £541,890.00 | £389,699.00 | £389,699.00 | £389,339.00 |
| Share Premium | £6.12 m | £5.94 m | £5.94 m | £5.93 m |
| Profit / Loss | -£668,754.00 | -£572,009.00 | -£358,972.00 | -£336,930.00 |
| Other Equity | £282,527.00 | £531,720.00 | £974,807.00 | £1.17 m |
| Preference & Minorities | 0 | 0 | 0 | 0 |
| Total Capital Employed | £282,527.00 | £531,720.00 | £974,807.00 | £1.17 m |
| Ratios | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 | 0 |
| Assets / Equity | 1.4958 | 1.4958 | 1.4958 | 1.4958 |
| Cash / Equity | 0.6763 | 0.6763 | 0.6763 | 0.6763 |
| EPS | £-0.00 | £-0.00 | £-0.00 | £-0.00 |
| Cash Flow | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Cash from operating activities | -£548,133.00 | -£266,587.00 | -£349,393.00 | -£32,607.00 |
| Cashflow before financing | -£210,305.00 | -£266,587.00 | -£346,548.00 | £11,633.00 |
| Increase in Cash | -£225,520.00 | -£271,082.00 | -£355,776.00 | -£4,410.00 |
| Income | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Turnover | £543,250.00 | £597,354.00 | £830,266.00 | £702,314.00 |
| Cost of sales | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| Operating Profit | -£670,816.00 | -£573,733.00 | -£359,114.00 | -£337,040.00 |
| Pre-Tax profit | -£668,754.00 | -£572,009.00 | -£358,972.00 | -£336,930.00 |
Physiomics PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Physiomics PLC is a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses to transform oncology drug development. The company operates in the UK, European Union Switzerland and USA. |
| Latest Interim Date | 7 Mar 2024 |
| Latest Fiscal Year End Date | 27 Sep 2024 |
Physiomics PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-05-31 | Dr. Christophe D Chassagnole | Executive Director,Chief Scientific Officer |
| 2022-02-23 | Dr. Paul Bernard Harper | Non-Executive Director,Chairman |
| 2007-06-30 | Mr. John Kingston Pool | Non-Executive Director,Chairman |
| 2006-08-29 | Mr. Duncan John Lipscombe | Non-Executive Director |
| 2017-11-09 | Mr. Mark Philip Chadwick | Non-Executive Director |
| 2024-10-17 | Dr. James Simon Millen | Non-Executive Director,Chairman |
| 2024-11-08 | Dr. Peter Joseph Sargent | Executive Director,Chief Executive Officer |
Physiomics PLC Contact Details
| Company Name | Physiomics PLC |
|---|---|
| Address | The Magdalen Centre, Robert Robinson Avenue, Oxford, OX4 4GA |
| Telephone | +44 1865784980 |
| Website | https://www.physiomics.co.uk |
Physiomics PLC Advisors
| Stockbroker | Hybridan LLP |
|---|---|
| Phone | +44 203764 2341 |
| Fax | +44 2076001586 |
| Financial Adviser | WH Ireland Ltd |
|---|---|
| Phone | 0161 832 2174 |
| Fax | 0161 819 8897 |
| Auditor | Shipleys LLP |
|---|---|
| Phone | +44 2073120000 |
| Fax | +44 2073120022 |
| Bank | National Westminster Bank PLC |
|---|
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Financial PR Adviser | Communications Portfolio (The) |
|---|---|
| Phone | 020 7536 2028 |
| Stockbroker | WH Ireland Ltd |
|---|---|
| Phone | 0161 832 2174 |
| Fax | 0161 819 8897 |
| Solicitor | Taylor Vinters |
|---|---|
| Phone | +44 1223423444 |
| Fax | +44 1223423486 |
| Nominated Adviser | WH Ireland Ltd |
|---|---|
| Phone | 0161 832 2174 |
| Fax | 0161 819 8897 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| North Atlantic Smaller Companies Investment Trust PLC | 3,770.00 | 4.72 |
| Harworth Group PLC | 176.50 | 4.44 |
| Mobico Group PLC | 79.85 | 4.17 |
| Ithaca Energy PLC | 107.00 | 3.88 |
| Airtel Africa PLC | 112.80 | 3.87 |
| Bakkavor Group PLC | 149.50 | 3.82 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Vistry Group PLC | 547.50 | -16.28 |
| Persimmon PLC | 1,182.00 | -2.39 |
| Entain PLC | 681.40 | -1.25 |
| Firstgroup PLC | 164.40 | -1.20 |
| Jpmorgan Japanese Investment Trust PLC | 555.00 | -1.07 |
| Puretech Health PLC | 154.80 | -1.02 |
Risers/fallers data from previous trading day.